Skip to content

Cell-free MSC secretome therapy ameliorates diabetic testicular injury via antioxidant mechanisms

Jul 2026 · Journal of Molecular Histology · Vol 57 · 0 citations · 37 references
Medicine

TL;DR

It is suggested that MSC-CM, particularly N-CM, may alleviate diabetes-induced testicular damage by restoring oxidative balance and preserving seminiferous tubule ultrastructure.

View source

Similar papers

Open access Sep 2026

Effects of Mesenchymal Stem Cell-Derived Secretome on Glycemic Control and Pancreatic Islet Morphology in Streptozotocin-Induced Diabetic Rats

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia and progressive pancreatic islet dysfunction. The mesenchymal stem cell (MSC)-derived secretome has been investigated as a potential cell-free therapeutic approach because of its reported paracrine, anti-inflammatory, and tissue...

Tena Djuartina · 0 citations
Open access Sep 2026

Probiotic-Derived Exopolysaccharides Enhance Mesenchymal Stem Cell-Mediated Fibroblast Repair under Hyperglycemic Conditions

Diabetic wounds are closely associated with persistent oxidative stress, decreased fibroblast activity, and delayed tissue regeneration under hyperglycemic conditions. These pathological features particularly complicate wound healing and often lead to chronic non-healing wounds. Recently, mesenchymal stem cells (MSCs...

Mesude Biçer, Mert Akdur, Esra Battal et al. · 0 citations
Sep 2026

CCBE1 promotes wound healing in diabetic rats by improving the functional impairment of AD-MSCs induced by AGEs.

OBJECTIVE The etiology of chronic and non-healing diabetic wounds is manifold; the progression of the non-healing phenotype is strongly associated with poor vascular networks. Mesenchymal stem cells (MSCs) are reckoned as a promising therapy for wound healing, especially in angiogenesis. Here, we explored the role of C...

Fang Liang, Jia-Ke Mo, Jia-Qi Zhang et al. · 0 citations
Sep 2026

Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes.

BACKGROUND Insulin resistance, metabolic dysfunction, inflammation, and vascular impairment characterize Type 2 Diabetes Mellitus (T2DM). Mesenchymal stem cells (MSCs) have shown promise in preclinical studies. However, their variable efficacy in human settings warrants strategies to enhance their therapeutic potency....

N. Mante, V. Undale, Avinash Sanap et al. · 0 citations
Open access Aug 2026

The Effect of Placental Mesenchymal Stem Cells on The Protection of Chronic Renal Failure: The Role of Adiponectin

Chronic glomerular and tubulointerstitial fibrosis represents a major pathological process leading to end-stage renal failure. Mesenchymal stem cell (MSC) therapy has emerged as a promising approach for renal tissue repair. The identification of molecular markers associated with disease progression may contribute to th...

Ezgi Akan, Mehmet Sakıncı, G. Süleymanlar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.